Mitotane should not be used for more than a few years.

Mitotane is a drug used to treat adrenocortical cancer, adrenocortical hyperplasia, and tumor-induced hypercortisolism. It exerts its therapeutic effects by interfering with the growth cycle of adrenocortical cancer cells. In patients with adrenocortical cancer, the duration of mitotane use may vary significantly depending on the condition.

If mitotane is used as first-line treatment, doctors will develop a treatment plan based on the patient's specific condition and physical condition. Generally speaking, a relatively high dose is used at the beginning of treatment, and then the dose is adjusted based on the patient's tolerance and efficacy. At this stage, treatment may continue for months or even years until the condition is under control or the patient becomes unable to tolerate the side effects of the medication.

If mitotane is used as second-line or subsequent treatment, its duration may be longer. This is because these patients have often received multiple treatments, their conditions are relatively complex, and they require longer periods of drug control.

The duration of mitotane use is highly individualized, and each patient's treatment plan will be tailored to their individual circumstances. During the use of mitotane, doctors will regularly evaluate the patient's condition and the effectiveness of the drug, as well as the drug's side effects. Based on these evaluations, your doctor may adjust the dosage of your medication or your treatment regimen. In some patients, long-term use of mitotane may be required to maintain stable disease. In this case, the doctor will develop a long-term management plan based on the patient's specific circumstances. If mitotane doesn't work well or if you develop serious side effects, your doctor may consider discontinuing the drug or switching to another treatment.

References:

https://www.sciencedirect.com/topics/medicine-and-dentistry/mitotane

xa0